(Q43534981)

English

Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT).

scientific article published on 30 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT). (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute decompensated heart failure

1 reference

based on heuristic

inferred from title

Aldo P. Maggioni

object named as

Aldo Maggioni

11

0 references

Gregg C. Fonarow

object named as

Gregg C Fonarow

4

0 references

Mihai Gheorghiade

1

object named as

Mihai Gheorghiade

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

3

object named as

Faiez Zannad

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Claudio R Gimpelewicz

6

object named as

Claudio Gimpelewicz

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

9

object named as

Eldrin F Lewis

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

7

object named as

Jaco Botha

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Mazen Albaghdadi

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Michael Böhm

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Shelley Moores

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Henning Rattunde

10

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ASTRONAUT investigators and study coordinators

12

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

30 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

100-106

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Heart failure-related hospitalization in the U.S., 1979 to 2004.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

The current and future management of acute heart failure syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Acute heart failure syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Neurohormonal inhibition in heart failure: insights from recent clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Acute heart failure syndromes: current state and framework for future research

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

"Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Oral renin inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Managing cardiovascular and renal risk: the potential of direct renin inhibition

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Cardiorenal interactions: insights from the ESCAPE trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Aliskiren combined with losartan in type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Overview of emerging pharmacologic agents for acute heart failure syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ209

21 January 2018

Identifiers

10.1093/EURJHF/HFQ209

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43534981&oldid=2098161506"